Sickle cell disease (SCD) or sickle cell anemia affects the lives of millions of people all over the world but is becoming a more manageable ailment than most might think.
A research team headed by Duke Medicine and Jenomic (a privately owned cancer research company) has developed a way to utilize sickle blood cells to combat cancerous tumors.